Collegium Pharma (COLL) Announces $25 Million Accelerated Share Repurchase Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. SMCI
6. COF
7. GOOGL
8. RTX
9. TSLA
10. S

Go back to Collegium Pharma (COLL) Announces $25 Million Accelerated Share Repurchase Program

Collegium Announces $25 Million Accelerated Share Repurchase Program

November 15, 2021 8:30 AM EST

STOUGHTON, Mass., Nov. 15, 2021 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company committed to being the leader in responsible pain management, today announced that it has entered into an Accelerated Share Repurchase ("ASR") agreement with Jefferies LLC to repurchase $25 million of the Companys common stock. Collegium will execute the ASR as part of the $100 million share... More